Ultragenyx Pharmaceutical Inc. (52) | Uncategorized (6)
Recent Contracts
-
Open Market Sale Agreement, dated May 7, 2021, by and between Ultragenyx Pharmaceutical Inc. and Jefferies LLC
(Filed With SEC on May 7, 2021)
-
Amendment dated October 9, 2020 to the Offer Letter between Mardi C. Dier and Ultragenyx Pharmaceutical Inc. dated August 28, 2020
(Filed With SEC on October 13, 2020)
-
Offer Letter between Mardi C. Dier and Ultragenyx Pharmaceutical Inc. dated August 28, 2020
(Filed With SEC on September 2, 2020)
-
Offer Letter, dated May 16, 2017, by and between Ultragenyx Pharmaceutical Inc. and Erik Harris
(Filed With SEC on August 2, 2019)
-
Addendum #1, dated August 8, 2017, to Offer Letter dated May 16, 2017 between Ultragenyx Pharmaceutical Inc. and Erik Harris
(Filed With SEC on August 2, 2019)
-
Addendum #2, dated June 19, 2019, to Offer Letter dated May 16, 2017 between Ultragenyx Pharmaceutical Inc. and Erik Harris
(Filed With SEC on August 2, 2019)